Private Equity

Updated:

Lapam Capital

Lapam Capital is a healthcare-focused venture capital firm. It targets early-stage and fast-growing opportunities.

Lapam Capital

Lapam Capital is a healthcare-focused venture capital firm. It targets early-stage and fast-growing opportunities. Lapam Capital has made 101 investments, including a Seed VC investment in Maibo Zhixing on March 23, 2026. The firm has 12 portfolio exits, with Leads Biolabs exiting on July 25, 2025.

General information

Firm type

Private Equity

Year founded

AUM

Undisclosed

Location

Region

Asia

Country

China

City

Beijing

Corporate office

Beijing, China

Sector focus

Enterprise SoftwareAI/MLDigital HealthIndustrial Tech

Frequently asked questions

What investment stages does Lapam Capital target?

Lapam Capital deploys across early-stage seed, start-up, and growth equity rounds. The firm can enter at university spinout stage and follow on through Series A and later rounds, concentrating capital in mainland China's hard-technology and enterprise sectors.

How does Lapam Capital source deals?

The firm's sourcing model draws on relationships with university technology transfer offices, state-backed guidance funds, and China's three primary venture hubs — Beijing, Shenzhen, and Shanghai. Deal flow is closely tied to government technology roadmaps and the policy cycles that determine when procurement budgets or subsidies become available for sectors like semiconductors and AI infrastructure.

Does Lapam Capital take minority or majority positions?

Public records do not detail Lapam's ownership preferences. Given the firm's stage coverage and the structure of China's domestic venture market — where state funds often anchor rounds — Lapam likely participates as a minority investor alongside government co-investors and corporate strategic partners rather than pursuing control positions.

Which sectors does Lapam explicitly avoid?

Lapam Capital does not publish exclusion lists. Its portfolio composition and policy-aligned mandate suggest the firm avoids consumer-facing internet platforms and business models that fall outside state-designated strategic technology priorities. No real estate, entertainment, or traditional consumer-goods investments appear in its disclosed posture.

How is Lapam Capital funded?

The firm's limited partner base is not publicly disclosed. Chinese private equity firms of Lapam's profile commonly raise capital from domestic institutional investors, government guidance funds, state-owned enterprise subsidiaries, and high-net-worth individuals. No foreign LP relationships are publicly documented.

What is Lapam Capital's exit strategy?

Given its portfolio concentration in sectors designated as strategic under Chinese industrial policy, Lapam's likely exit routes include domestic A-share IPOs on the STAR Market in Shanghai or Shenzhen's ChiNext board. These venues have become the standard liquidity path for Chinese deep-tech companies, particularly since tightened offshore listing rules and US-China audit tensions narrowed foreign exit options.

Does Lapam Capital co-invest alongside external GPs?

Lapam's structure supports co-investment activity, most frequently alongside Chinese state-backed funds and corporate venture arms aligned with the same industrial-policy priorities. The firm does not market co-investment programs to international GPs, and its capital is deployed exclusively within mainland China.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Beijing Private Equity profiles